All GLG News Analyses Filed Under: Business of Medicine
Analyses are solely the work of the authors and have not been edited or endorsed by GLG.
-
Genentech and Dako Collaborate To Increase Herceptin Use In Gastric Cancer
August 18, 2009
Dako enters collaboration with Genentech on diagnostic tests for patients with stomach cancer | www.pipelinereview.com
Phase III data presented at ASCO in 2009 demonstrated a benefit for patients with HER-2 overexpressing gastric cancer who received Herceptin. Dako, the developer of the HercepTest and Genetech, the manufacturer of Herceptin, have joined forces to increase HER2 testing and Herceptin utilization.
-
SUN PHARMA GETS US NOD FOR 2 GENERIC Drugs
August 18, 2009
Sun Pharma gets US nod for two generic drugs | economictimes.indiatimes.com
It will definetly boost the share price if SUN Pharma in India and it help to increse the share of sales in US marketing
-
Global Pharma Business set for a complete Make Over!!!!
August 18, 2009
Big pharma companies join outsourcing queue | www.business-standard.com
Pharma - Healthcare cost - People - Politics - Government - Power. This is the long link & effect of pharma on global stage !!! Every Government especially US is crying one chores "Cut Healthcare Cost" With India having the largest US FDA approved set of manufacturing facilities outside US, India becomes a natural partner. As the article suggests, outsourcing deals will get bigger & broader. Pharma will soon see the revolution seen couple of years back in India IT industry!!!
-
Is Aurobindo trying to do a Satyam on its investors!!!
August 18, 2009
Aurobindo Pharma to Buy Trident Life for About $27.85 Million | online.wsj.com
With memories of Satyam Infotech $ 2 billion scam fresh in everyone's mind, it is a very wrong move by Aurobindo. During consultations investors had asked me this very question "Corporate Governance" My reply was, this is one thing difficult to predict. Aurobindo which has built it's trust over decades should stay away from such moves. Specially when the target company or the company to be bough belongs to your son!!!
-
2 generic drugs - Imitrex and Eloxatin
August 16, 2009
Sun Pharma gets US nod for two generic drugs | economictimes.indiatimes.com
I do not have a problem with a generic-like Imitrex. I do for Eloxatin. Generics can be up to 20% off, so for migraine med, that is more acceptable than a cancer treatment.
-
August 14, 2009
Orchid gets USFDA approval for migraine drug | economictimes.indiatimes.com
I read the article re 'Orchid gets USFDA approval for migraine drug'. This refers to Sumatriptan, 25mg, 50mg and 100mg.
-
Have You Looked at Clouds from Both Sides Now?
August 14, 2009
Making the 'Big Switch' to Cloud Computing | www.modernhealthcare.com
Are we at an inflection point in the history of computing? Are we entering a period of inevitable conversion from mainframe, client server and local network technologies, overwhelmingly the dominant models in clinical health care computing today, to the next generation of offsite, remotely hosted ad managed services via the "World Wide Computer" (otherwise known as 'cloud computing')?
-
Indian set to become the HUB of Clinical Research
August 9, 2009
India a preferred destination for clinical trials: Study- Biotech-Healthcare / Biotech-News By Industry-News-The Economic Times | economictimes.indiatimes.com
The Report says it all !!! Cost of RnD , Clinical trials and related activities required for drug development have escalated beyond justifiable levels in developed nations. In order to continuously innovate & keep the drug pipeline humming, a shift in process was required and India was the answer!!! With its inherent cost advantage & pool of highly skilled & qualified people it's a safe bet.
-
Aurobindo continues to strenghten its presence in US Markets!!
August 9, 2009
Aurobindo gets FDA nod for muscle relaxant | www.business-standard.com
Aurobindo is one of the few Indian company's which has understood the US regulatory really well. It has the largest number of US FDA approved manufacturing facilities. And to complement that it has the highest number of products approved by USFDA. This particular new addition to the family is all set to contribute significantly to their bottom line.
-
How Accountable Care Organizations may Provide the Bridge to a Bipartisan Bill
August 7, 2009
Health Policy is Carved out at Table for 6 | www.nytimes.com
It would seem that at least until September 15 (the deadline imposed by Max Baucus, D-Montana, and Chairman of the Senate Finance Committee when there will be a vote on the legislation crafted by that time with or without Republican support), national healthcare reform is being held hostage by a "Gang of Six" U.S. Senators--sometimes known in recent military lingo as the "Coalition of the Willing". The other 529 members of Congress appear to be mere pawns in the process until that fateful day
- Subscribe to Updates
-
Leading institutions connect with members of the Healthcare councils through GLG
Get Intelligently Connected
with the world's leading experts
GLG's 850+ Clients Include:
- More than 70% of the world's leading
- mutual funds
- 15 of the leading 20
- global banks
- 7 of the leading 10
- global private equity firms
- 5 of the leading 10
- AmLaw firms
- Fortune 500® Companies
- in nearly every industry sector, including pharmaceuticals, insurance, chemicals, energy and computer software
Most Popular Business of Medicine News
-
Pharma Outsourcing: Where Will it End?
November 3, 2009
-
What does Solvay offer to a bidder ?
September 25, 2009
-
Talecris Biotherapeutics Proposes IPO; Hits Favorable Timing Window
September 23, 2009
-
Health Care Reform Debate 2009 ~ Blind Rush to Rash Decisions
September 23, 2009
-
Why Health Care Costs Keep Rising—And What to Do About It
September 13, 2009